Biomarkers of (osteo)arthritis

Biomarkers

Volumn 20, Issue 8, 2015, Pages 513-518

  Mobasheri, Ali ^a,b,c   Henrotin, Yves ^d,e  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e Princess Paola Hospital   (Belgium)

Author keywords

Arthritis; Biomarker; Diagnostic; Musculoskeletal disorders; Osteoarthritis; Prognostic

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; MEMBRANE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; VOLTAGE DEPENDENT ANION CHANNEL;

ARTHRITIS; ARTHROPATHY; DIAGNOSTIC PROCEDURE; HUMAN; OSTEOARTHRITIS; PROGNOSIS; REVIEW; RISK FACTOR; SCIENTIFIC LITERATURE; SYNOVITIS; X RAY FILM; ANIMAL; EARLY DIAGNOSIS; JOINT; METABOLISM; PREDICTIVE VALUE;

ANIMALS; ARTHRITIS; BIOMARKERS; EARLY DIAGNOSIS; HUMANS; JOINTS; OSTEOARTHRITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84962600341     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2016.1140930     Document Type: Review

References (60)

1. Abella V, Scotece M, Conde J, et al. (2015). The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1123354
2. Archer CW, Francis-West P. (2003). The chondrocyte. Int J Biochem Cell Biol 35: 401-4
3. Aspden RM, Scheven BA, Hutchison JD. (2001). Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 357: 1118-20
4. Bauer DC, Hunter DJ, Abramson SB, et al. (2006). Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthr Cartil 14: 723-7
5. Bay-Jensen AC, Reker D, Kjelgaard-Petersen CF, et al. (2016). Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria. Osteoarthr Cartil 24: 9-20
6. Berenbaum F. (2013). Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil 21: 16-21
7. Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95
8. Bliddal H, Leeds AR, Christensen R. (2014). Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons-a scoping review. Obes Rev 15: 578-86
9. Braun HJ, Gold GE. (2012). Diagnosis of osteoarthritis: imaging. Bone 51: 278-88
10. Buckwalter JA, Mankin HJ. (1998). Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47: 487-504
11. Chockalingam PS, Sun W, Rivera-Bermudez MA, et al. (2011). Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. Osteoarthr Cartil 19: 315-23
12. Collins FS, Varmus H. (2015). A new initiative on precision medicine. N Engl J Med 372: 793-5
13. Conaghan PG. (2013). Osteoarthritis in 2012: parallel evolution of OA phenotypes and therapies. Nat Rev Rheumatol 9: 68-70
14. Courties A, Gualillo O, Berenbaum F, Sellam J. (2015). Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthr Cartil 23: 1955-65
15. Cross M, Smith E, Hoy D, et al. (2014). The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73: 1323-30
16. Daghestani HN, Kraus VB. (2015). Inflammatory biomarkers in osteoarthritis. Osteoarthr Cartil 23: 1890-6
17. De Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, et al. (2012). Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthr Cartil 20: 1484-99
18. Dvir-Ginzberg M, Reich E. (2014). Chopping off the chondrocyte proteome. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2014.955884
19. Felson DT, Anderson JJ, Naimark A, et al. (1988). Obesity and knee osteoarthritis. The Framingham study. Ann Intern Med 109: 18-24
20. Felson DT, Niu J, Neogi T, et al. (2015). Synovitis and the risk of knee osteoarthritis: the MOST Study. Osteoarthr Cartil 12: 177-90
21. Greene MA, Loeser RF. (2015). Aging-related inflammation in osteoarthritis. Osteoarthr Cartil 23: 1966-71
22. Haugen IK, Ramachandran VS, Misra D, et al. (2013). Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham heart study. Ann Rheum Dis 74: 74-81
23. Hedbom E, Antonsson P, Hjerpe A, et al. (1992). Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267: 6132-6
24. Henrotin Y, Clutterbuck AL, Allaway D, et al. (2010). Biological actions of curcumin on articular chondrocytes. Osteoarthr Cartil 18: 141-9
25. Henrotin Y. (2012). Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthr Cartil 20: 215-17
26. Henrotin Y, Sanchez C, Cornet A, et al. (2015). Soluble biomarkers development in osteoarthritis: from discovery to personalized medicine. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1123363
27. Hunter DJ, Nevitt M, Losina E, Kraus V. (2014). Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract Res Clin Rheumatol 28: 61-71
28. Jahr H, Brill N, Nebelung S. (2015a). Detecting early stage osteoarthritis by optical coherence tomography? Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1130190
29. Jahr H, Matta C, Mobasheri A. (2015b). Physicochemical and biomechanical stimuli in cell-based articular cartilage repair. Curr Rheumatol Rep 17: 22. DOI: 10.1007/s11926-014-0493-9
30. Kanis JA, Oden A, Johansson H, et al. (2009). FRAX and its applications to clinical practice. Bone 44: 734-43
31. Kjelgaard-Petersen CF, Siebuhr AS, Christiansen T, et al. (2015). Synovitis biomarkers: ex vivo characterisation of three biomarkers for identification of inflammatory osteoarthritis. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1105497
32. Kluzek S, Newton JL, Arden NK. (2015a). Is osteoarthritis a metabolic disorder? Br Med Bull 115: 111-21
33. Kluzek S, Arden NK, Newton J. (2015b). Adipokines as potential prognostic biomarkers in patients with acute knee injury. Biomarkers 26: 1-7
34. Kluzek S, Bay-Jensen A-C, Judge A, et al. (2015c). Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1105498
35. Krawetz R, Ren G. (2015). Applying computation biology and "big data" to develop multiplex diagnostics for complex chronic diseases such as osteoarthritis. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1105499
36. Lafeber FP, van Spil WE. (2013). Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthr Cartil 21: 1452-64
37. Larsson S, Englund M, Struglics A, Lohmander LS. (2012). The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study. Osteoarthr Cartil 20: 388-95
38. Lawrence RC, Helmick CG, Arnett FC, et al. (1998). Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41: 778-99
39. Liu-Bryan R, Terkeltaub R. (2014). Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 11: 35-44
40. Lohmander LS, Saxne T, Heinegård DK. (1994). Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 53: 8-13
41. Lotz M, Martel-Pelletier J, Christiansen C, et al. (2013). Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 72: 1756-63
42. Louati K, Vidal C, Berenbaum F, Sellam J. (2015). Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open 1: e000077
43. Matta C, Zhang X, Liddell S, et al. (2015). Label-free proteomic analysis of the hydrophobic membrane protein complement in articular chondrocytes: a technique for identification of membrane biomarkers. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1130191
44. Mobasheri A, Matta C, Zákány R, Musumeci G. (2015). Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis. Maturitas 80: 237-44
45. Mobasheri A. (2012). Osteoarthritis year 2012 in review: biomarkers. Osteoarthr Cartil 20: 1451-64
46. Mobasheri A. (2013a). The future of osteoarthritis therapeutics: targeted pharmacological therapy. Curr Rheumatol Rep 15: 364. DOI: 10.1007/s11926-013-0364-9
47. Mobasheri A. (2013b). The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep 15: 385. DOI: 10.1007/s11926-013-0385-4
48. Orlowsky EW, Kraus VB. (2015). The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol 42: 363-71
49. Prior JA, Jordan KP, Kadam UT. (2014). Associations between cardiovascular disease severity, osteoarthritis co-morbidity and physical health: a population-based study. Rheumatology 53: 1794-802
50. Rashidifard C, Vercollone C, Martin S, et al. (2013). The application of optical coherence tomography in musculoskeletal disease. Arthritis 2013: 563268
51. Roos EM, Arden NK. (2015). Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol 12: 92-101
52. Rousseau JC, Delmas PD. (2007). Biological markers in osteoarthritis. Nat Clin Pract Rheumatol 3: 346-56
53. Rousseau JCH, Garnero P. (2012). Biological markers in osteoarthritis. Bone 51: 265-77
54. Sandell LJ, Aigner T. (2001). Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 3: 107-13
55. Sandell LJ. (2012). Etiology of osteoarthritis: genetics and synovial joint development. Nat Rev Rheumatol 8: 77-89
56. Scanzello CR, Goldring SR. (2012). The role of synovitis in osteoarthritis pathogenesis. Bone 51: 249-57
57. Scotece M, Mobasheri A. (2015). Leptin in osteoarthritis: focus on articular cartilage and chondrocytes. Life Sci 140: 75-8
58. Sellam J, Berenbaum F. (2013). Is osteoarthritis a metabolic disease? Joint Bone Spine 80: 568-73
59. Swan AL, Stekel DJ, Hodgman C, et al. (2015). A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data. BMC Genomics 16: S2
60. Wang Q, Rozelle AL, Lepus CM, et al. (2011). Identification of a central role for complement in osteoarthritis. Nat Med 17: 1674-9